Explore the future of diabetes care, highlighting novel therapies and technologies. This article delves into CGM advances, once-weekly insulin, prevention therapies, and...

Author Christine Fallabel, who has had type 1 diabetes since 2000, shares a powerful perspective on what she’s felt like living with the condition. Fallabel and others...

At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...

Explore how beans can play a pivotal role in managing diabetes. Learn about the health benefits, including fiber, protein, and low GI, and the best types to include in...

A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...

Dexcom's new CGM system caters to non-insulin using type 2 diabetes patients, offering continuous glucose readings and personalized features.

Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...

PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.

Trying to figure out the best nutrition options as a person with diabetes can be a daunting task, and often there are mixed messages about what the best food options are.

Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.

A panel shared insights at the ADA’s 83rd Scientific Sessions on incorporating hypoglycemia as a quality measure in diabetes. Each expert noted the importance of...

Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...

In this ADA session, experts discussed comprehensive therapies, coordinated care, and the role of pharmacists in improving your health.

Figuring out when and how to exercise can be one of the most difficult parts of living with diabetes. At the ADA's 83rd Scientific Sessions, experts shared strategies...

People with type 1 and 2 diabetes report experiencing diabetes stigma regardless of which devices they use. But when we start looking at which groups report the most...

end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.

New drug treatments are now available for children with diabetes following the recent approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...

Join diaTribe at the American Diabetes Association's 83rd scientific conference for insights on future diabetes care, medication, and the latest tech. Plus, explore...

Explore Glitter Glucose’s guide on managing diabetes in summer from outdoor activity tips to device care. Includes a low-carb, sugar-free popsicle recipe for hot days.

Understand the stigma linked to medication use for diabetes and obesity management. Let's change the perception and enhance our healthcare conversations.